Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Biology

Background:

• Macrophages are key players in diseases such as cancer and atherosclerosis.
• Targeting macrophage activity presents a therapeutic opportunity.
• CD206 (mannose receptor) is upregulated on tumor-associated macrophages, making it a potential therapeutic target.

Purpose of the Study:

• To design and characterize pH-responsive, mannosylated polymeric micelles for targeted siRNA delivery.
• To evaluate the efficiency of these nanoparticles in delivering siRNA into macrophages.
• To assess the potential of this platform for treating CD206-expressing macrophage-related diseases.

Main Methods:

• Synthesis of pH-responsive polymeric micelles.
• Functionalization of micelles with mannose using "click" chemistry for CD206 targeting.
• In vitro assessment of siRNA delivery and gene knockdown in primary and human macrophages.
• Comparison of targeted vs. non-targeted nanoparticle delivery efficiency.

Main Results:

• Mannosylated nanoparticles showed a 4-fold increase in siRNA delivery into primary macrophages compared to non-targeted carriers.
• Achieved 87% gene knockdown in primary macrophages, a cell type typically difficult to transfect.
• Human macrophages internalized targeted nanoparticles, with 13-fold greater siRNA delivery than in breast cancer cell lines.

Conclusions:

• Mannose receptor-targeted, endosomolytic siRNA nanoparticles effectively deliver siRNA into macrophages.
• This technology shows promise for targeting macrophage activity in diseases, particularly where CD206 is upregulated.
• The platform is generalizable for "click" functionalization with other targeting ligands for diverse siRNA delivery applications.